Sublingual apomorphine
US9326981B2 · kind B2 · utility
4Cited by
38References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2015 |
| Grant date | May 3, 2016 |
| Priority date | — |
| Expiry date | Apr 10, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T428/2982
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods involving the use of sublingual film formulations of apomorphine for treating Parkinson's disease. The methods involve providing the sublingual film formulation and administering the sublingual film formulation sublingually in the mouth of a subject by contacting sublingual mucosal tissue with the film.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.